Inventor · disambiguated record
Matthew A. Naylor
Also filed as: NAYLOR MATTHEW · NAYLOR MATTHEW A · NAYLOR MATTHEW ALEXANDER
5 granted patents·4 pending applications·66 citations·filing 1993–2005
81Inventor score
Files withWARNER LAMBERT CO2ANGIOGENE PHARM LTD1BRITISH TECH GROUP1BRITISH TECHNOLOYG GROUP LIMIT1GRAY LAB CANCER RES TRUST1
Top patents by PatentIndex Score
9 records- 0188US5342959AProcess for preparing chiral [[(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazol-1-ethanol and related compoundsWARNER LAMBERT CO·Filed 1993·Granted Aug 30, 1994·31 cites·2 claims
- 0275US5481000AProcess for preparing chiral [[(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazol-1-ethanol and related compoundsWARNER LAMBERT CO·Filed 1994·Granted Jan 2, 1996·11 cites·1 claims
- 0371US5659048AChiral [[(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazol-1-ethanol and related compoundsBRITISH TECH GROUP·Filed 1995·Granted Aug 19, 1997·11 cites·4 claims
- 0470US5543527AProcess for preparing chiral [[(2-bromoethyl)-amino]methyl]-nitro-1H-imidazol-1-ethanol and related compoundsBRITISH TECHNOLOYG GROUP LIMIT·Filed 1995·Granted Aug 6, 1996·13 cites·3 claims
- 0540US2006223827A1Bioreductively activated stilbene prodrugsSIEMENS AG·Filed 2004·Application pending·0 cites
- 0638US2007099871A1Bioreductively-activated prodrugsGRAY LAB CANCER RES TRUST·Filed 2004·Application pending·0 cites
- 0737US2008145372A1Bioreductively-Activated ProdrugsANGIOGENE PHARM LTD·Filed 2005·Application pending·0 cites
- 0835US2009202571A1Bioreductively-activated prodrugsHOPNIC LAB CO LTD·Filed 2005·Application pending·0 cites
- 0920US7829555B1Drug targetingUNIV MANCHESTER·Filed 1998·Granted Nov 9, 2010·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →